Analysis of the Effect of Traditional Chinese Medicine Nursing Intervention Combined with Acupoint Application in The Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Objective:To study the effect of Traditional Chinese medicine(TCM)nursing intervention combined with acupoint patch in the treatment of acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods:A total of 60 patients with acute exacerbation of COPD admitted between September 2022 and September 2023 were selected and randomly grouped into a control group(conventional care and treatment)and an observation group(joint interventions:traditional Chinese medicine nursing interventions,acupoint compresses),with 30 patients each.The arterial blood gas indexes of the two groups,hospitalization time,pulmonary function indexes,and TCM symptom scores were analyzed and compared between the two groups.Results:The arterial oxygen pressure(PaO_(2))(9.52±1.02 kPa)and partial pressure of carbon dioxide(PaCO_(2))(5.01±1.02 kPa)of the observation group were better than those of the control group after the intervention(P<0.05).The forced expiratory volume(FEV1)(3.38±0.15%),the FEV1% prediction value(72.52±2.25),and the FEV1/forced vital capacity(FVC)(79.52±1.41%)were higher than those of the control group(P<0.05).The hospitalization time(12.16±1.02 d)and TCM symptom score(4.12±1.26)of the observation group were better than those of the control group(P<0.05).Conclusion:Significant nursing effects were achieved by carrying out combined interventions(Chinese medicine nursing intervention and acupoint application)during the acute exacerbation of COPD.

Comparison of Protein Profiles in Sputum between COPD and Acute Exacerbation of COPD

Background and objective: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation that is associated with an abnormal inflammatory response of the lung to noxious particles or gases. Cigarette smoking is the major risk factor for the development of COPD. This study evaluated the levels of cyclophilin B in sputa from patients with COPD and COPD with acute exacerbation (AECOPD). Materials and Methods: Two-dimensional electrophoresis was used for differential display proteomics. Western blotting was used to identify and quantify cyclophilin B in sputum from subjects with AECOPD and COPD. Results: Forty-nine protein spots differed in relative intensity between the AECOPD (n = 6) and COPD (n = 6) subjects. Twenty proteins showed increased expression in the sputum of AECOPD subjects, and 29 proteins were present at lower levels in AECOPD sputum compared with COPD sputum. One of these proteins was associated with cyclophilin B. Cyclophilin B concentrations were lower in sputum from subjects with COPD (n = 4) versus AECOPD (n = 4). Conclusion: The sputum proteomic analysis suggests that changes in various proteins are associated with the development of AECOPD.

Correlation of serum CRP and PCT levels with systemic inflammatory response in patients with acute exacerbation of COPD

Objective:To investigate the correlation of serum C-reactive protein (CRP) and procalcitonin (PCT) levels with systemic inflammatory response in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD).Methods:68 patients with acute exacerbation of COPD treated in our hospital between August 2012 and February 2016 were collected as observation group and 50 normal subjects receiving physical examination in our hospital during the same period were selected as normal control group. Radioimmunoassay was used to determine serum CRP and PCT levels;the observation group was further grouped according to the median of CRP and PCT levels, and serum levels of pro-inflammatory factors, anti-inflammatory factors and stress hormones of high level group and low level group were detected.Results:Serum CRP and PCT levels of observation group were significantly higher than those of normal control group (P<0.05);serum pro-inflammatory factors interleukin-1β (IL-1β), interleukin-6 (IL-6) and interleukin-8 (IL-8) levels of high CRP and PCT level groups within observation group were higher than those of low CRP and PCT level groups (P<0.05), anti-inflammatory factors interleukin-4 (IL-4) and interleukin-13 (IL-13) levels were lower than those of low CRP and PCT groups (P<0.05), and stress hormones angiotensin II (Ang II), aldosterone (ALD) and cortisol (Cor) levels were higher than those of low CRP and PCT level groups (P<0.05).Conclusions:Serum CRP and PCT levels in patients with acute exacerbation of COPD are positively correlated with the inflammatory response extent in the body, and can be used as the auxiliary means for early disease diagnosis, treatment effect evaluation and prognosis judgment.

Value of refined care in patients with acute exacerbation of chronic obstructive pulmonary disease

BACKGROUND Under physiological conditions,sputum produced during acute exacerbation of chronic obstructive pulmonary disease(AECOPD)can move passively with the cilia in the airway;the sputum is gradually excreted from the depth of the airways through the stimulation of the coughing reflex on the sensory nerve on the surface of the airway.However,when the sputum is thick,the cough is weak,or the tracheal cilia are abnormal,sputum accumulation may occur and affect the exchange of oxygen and carbon dioxide in the lung.Furthermore,the presence of pathogenic microorganisms in sputum may cause or aggravate the symptoms of pulmonary infection in patients,which is the main factor leading to AECOPD.Therefore,promoting effective drainage of sputum and maintaining airway opening are key points requiring clinical attention.AIM To explore the effect of refined nursing strategies in patients with AECOPD and dysphagia.METHODS We selected 126 patients with AECOPD and difficulty of expectoration at our hospital,and divided them into a refined care group and a routine care group,with 63 cases each,using a random number table.The two groups of patients were treated with expectorant,anti-infection,oxygen inhalation,and other basic treatment measures;patients in the refined care group were given refined nursing intervention during hospitalization,and the routine care group received conventional nursing intervention.The differences in sputum expectoration,negative pressure suction rate,blood gas parameters,dyspnea score measured through the tool developed by the Medical Research Council(MRC),and quality of life were compared between the two groups.RESULTS After 7 d of intervention,the sputum expectoration effect of the refined care group was 62.30%,the effective rate was 31.15%,and the inefficiency rate was 6.56%.The sputum expectoration effect of the routine care group was 44.07%,the effective rate was 42.37%,and the inefficiency rate was 13.56%.The refined care group had better sputum expectoration than the routine care group(P<0.05).The negative pressure suction rate in the refined care group was significantly lower than that of the routine care group during the treatment(22.95%vs 44.07%,P<0.05).Before the intervention,the arterial oxygen saturation(PaO2)and arterial carbon dioxide saturation(PaCO2)values were not significantly different between the two groups(P>0.05);the PaO2 and PaCO2 values in the refined care group were comparable to those in the routine care group after 7 d of intervention(P>0.05).Before the intervention,there was no significant difference in the MRC score between the two groups(P>0.05);the MRC score of the refined care group was lower than that of the routine care group after 7 d of intervention,but the difference was not statistically significant(P>0.05).Before intervention,there was no significant difference in the symptoms,activities,disease impact,or St.George’s Respiratory questionnaire(SGRQ)total scores between the two groups(P>0.05).After 7 days of intervention,the symptoms,activities,and total score of SGRQ of the refined care group were higher than those of the routine care group,but the difference was not statistically significant(P>0.05).CONCLUSION AECOPD with thick sputum,weak coughing reflex,and abnormal tracheal cilia function will lead to sputum accumulation and affect the exchange of oxygen and carbon dioxide in the lung.Patients with AECOPD who have difficulty expectorating sputum may undergo refined nursing strategies that will promote expectoration,alleviate clinical symptoms,and improve the quality of life.

腹部肥胖对COPD急性加重的影响

目的探讨腹部肥胖相关指标对慢性阻塞性肺疾病(COPD)患者急性加重的影响。方法对“新疆多民族自然人群队列建设及健康随访研究”招募的和田墨玉县常住居民经肺功能检测诊断为COPD的患者,进行问卷及常规检查测量腰围,体成分检测内脏脂肪等级,计算腰高比、体重调整腰围指数(WWI),随访患者至少1年急性加重住院情况。以急性加重住院为结局分析腹部肥胖相关指标对COPD急性加重的影响,并比较不同腹部肥胖指标对COPD急性加重的预测价值。结果631名COPD患者经过随访,报告了186例COPD急性加重住院病例。整个随访期间,COPD急性加重和无急性加重患者在年龄、肺结核疾病史、吸烟、二手烟、烹饪和取暖燃料、慢阻肺患者评价评分(CAT评分)等方面的比较差异有统计学意义(均P<0.05)。单因素及模型1和2显示,腰围、腰高比、WWI、内脏脂肪等级均对COPD急性加重有影响,指标每增加一个单位急性加重均有增加;腰高比及内脏脂肪等级对COPD急性加重影响的结果较稳定,多重调整后腰高比OR=1.304(1.010~1.683),内脏脂肪等级OR=1.912(1.122~3.257)。腹部肥胖相关指标对COPD急性加重均有预测价值,其中WWI的曲线下面积最大,为0.614。结论腹部肥胖指标腰高比、WWI、内脏脂肪等级是COPD急性加重的危险因素,COPD的防控应考虑减少腹部肥胖的干预策略。

多索茶碱治疗COPD急性发作期的临床效果及对气道重塑和呼吸功能的影响

目的观察多索茶碱治疗慢性阻塞性肺疾病(COPD)急性发作期的临床效果及对气道重塑和呼吸功能的影响。方法选取2020年3月—2022年7月兰州市第二人民医院收治的COPD急性发作期患者70例,根据随机数字表法分为观察组和对照组,每组35例。在常规对症治疗基础上,观察组予多索茶碱治疗,对照组予氨茶碱治疗。比较2组治疗效果,治疗前后气道重塑血清指标[基质金属蛋白酶抑制因子-1(TIMP-1)、基质金属蛋白酶-3(MMP-3)、基质金属蛋白酶-9(MMP-9)、神经生长因子(NGF)]、呼吸功能指标[第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、呼气流量峰值(PEF)]、血气分析指标[动脉血氧分压(PaO_(2))、动脉血二氧化碳分压(PaCO_(2))、动脉血氧饱和度(SaO_(2))]。结果观察组治疗总有效率为94.29%,高于对照组的71.43%(χ2=6.437,P=0.011)。治疗后,2组TIMP-1、MMP-3、MMP-9、NGF水平较治疗前降低,且观察组低于对照组(P均<0.01);2组FEV_(1)、FVC、PEF较治疗前升高,且观察组高于对照组(P<0.05或P<0.01);2组PaO_(2)、SaO_(2)水平高于对照组,PaCO_(2)水平低于对照组,且观察组变化幅度大于对照组(P均<0.01)。结论多索茶碱治疗COPD急性发作期患者疗效确切,可有效促进血气分析指标、气道重塑、呼吸功能改善。

基于GC-TOFMS技术对痰浊壅肺型COPD急性加重期血清代谢组学研究

目的:研究痰浊壅肺型慢性阻塞型肺疾病急性加重期(AECOPD)患者血清代谢物的特异性变化。方法:采用气相色谱-飞行时间质谱联用(GC-TOFMS)技术检测60例痰浊壅肺型AECOPD患者和30例健康人的血清标本,用多元统计分析方法和t检验分析两组间的差异代谢物,关联相关代谢途径,解释痰浊壅肺型AECOPD患者的人体相应变化。结果:痰浊壅肺型AECOPD患者与健康组血清代谢轮廓存在明显的差异,找到其中17个差异代谢物。痰浊壅肺型AECOPD患者乳酸、琥珀酸、硫辛酸、新橙皮苷、D-神经鞘氨醇、葡萄糖、亚油酸甲酯、天门冬酰胺、尿素等15种物质表达均显著上调,而苏氨酸、牛磺酸显著下调。结论:痰浊壅肺型AECOPD患者能量代谢、脂肪代谢、氨基酸代谢等发生特异性变化,鉴定的差异代谢物可为痰浊壅肺型AECOPD患者的机制研究提供一条新的途径。

COPD急性加重期患者外周血单个核细胞SOCS-1、TLR4 mRNA及血清cTnT、尿酸水平变化分析

目的探讨慢性阻塞性肺疾病(COPD)急性加重期患者外周血单个核细胞中细胞因子信号抑制蛋白-1(SOCS-1)、Toll样受体4(TLR4)mRNA水平及血清心肌肌钙蛋白T(cTnT)、尿酸水平变化。方法收集COPD急性加重期(组)患者70例,COPD稳定期(组)患者40例,对照组健康志愿者40名。检测外周血单个核细胞SOCS-1、TLR4 mRNA水平及血清cTnT、尿酸浓度;行肺功能检查并记录相关指标(FEV1、FEV1%、FEV1/FVC%)。对COPD急性加重期患者进行1 a随访,分为预后不良组和预后良好组。对外周血单个核细胞SOCS-1、TLR4 mRNA水平、血清cTnT、尿酸浓度行Pearson相关性分析,并对COPD急性加重期患者预后评估价值进行ROC曲线分析。结果COPD急性加重期组SOCS-1 mRNA表达水平明显低于COPD稳定期组、对照组,TLR4 mRNA水平及血清cTnT、尿酸浓度明显高于COPD稳定期组和对照组(均P<0.01)。COPD急性加重期组FEV1、FEV1%、FEV1/FVC%明显低于COPD稳定期组和对照组(P<0.05)。COPD急性加重期患者FEV1/FVC%与外周血单个核细胞SOCS-1 mRNA表达水平呈正相关关系(P<0.01),与外周血单个核细胞TLR4 mRNA水平及血清cTnT、尿酸浓度呈负相关关系(P<0.01)。预后不良组SOCS-1 mRNA水平明显低于预后良好组,TLR4 mRNA水平及血清cTnT、尿酸浓度明显高于预后良好组(P<0.05)。外周血单个核细胞SOCS-1、TLR4 mRNA水平及血清cTnT、尿酸联合检测对COPD急性加重期患者预后具有较高的评估价值。结论COPD急性加重期患者SOCS-1低表达,TLR4、cTnT、尿酸高表达,且与肺功能水平密切相关,联合检测对患者预后具有较高的评估价值。

中性粒细胞与淋巴细胞比值和嗜酸性粒细胞对AECOPD患者出院后1年内COPD相关再入院的预测价值

目的探究中性粒细胞/淋巴细胞比率(NLR)和嗜酸性粒细胞计数(EOS)对慢性阻塞性肺疾病急性加重期(AECOPD)患者出院后1年内慢性阻塞性肺疾病(COPD)相关再入院的预测价值。方法将2020年12月至2022年6月阜阳市第二人民医院收治的100例AECOPD患者纳入本次回顾性研究,将出院后1年内有≥1次再入院记录的患者纳入再入院组(n=35),其他患者纳入非再入院组(n=65)。比较两组的临床资料(包括一般资料、实验室检查资料、治疗方法和死亡情况)。根据NLR、EOS的预测AECOPD再入院的受试者工作特征(ROC)曲线截断值将患者分组,分别为高NLR组(n=43)和低NLR组(n=57)、低EOS组(n=51)和高EOS组(n=49)。比较各组的住院时间、1年内COPD相关再入院情况和死亡情况,采用Logistic回归分析NLR、EOS预测AECOPD再入院的风险。结果再入院组患者住院时间为(16.68±6.44)d,明显长于非再入院组[(14.02±6.26)d],全身糖皮质激素使用患者比率为28.57%,明显少于非再入院组(53.85%),NLR为8.57±3.16,显著低于非再入院组(13.97±3.79),EOS为(0.25±0.07)×10^(9)/L,显著高于非再入院组[(0.12±0.06)×10^(9)/L],差异均有统计学意义(P<0.05)。低NLR组1年内COPD相关再入院次数和人数占比分别为(1.32±0.34)次、46.51%,均高于高NLR组[(0.83±0.31)次、26.32%],差异均有统计学意义(P<0.05)。高EOS组1年内COPD相关再入院次数和人数占比分别为(1.35±0.40)次、44.90%,均高于低EOS组[(0.81±0.37)次、25.49%],差异均有统计学意义(P<0.05)。Logistic回归分析显示,低NLR(<4.85)与高EOS(≥0.1×10^(9)/L)与1年内COPD相关的再入院风险相关[OR=4.394(95%CI:1.152~8.203);OR=4.699(95%CI:1.152~8.583)]。结论入院时的NLR和EOS可能与AECOPD患者出院后1年内COPD相关再入院有关,可作为预测出院后再住院的生物标志物。

小青龙汤加味联合西药治疗COPD急性加重期痰湿蕴肺证的临床疗效观察

目的观察小青龙汤加味联合西药治疗慢性阻塞性肺疾病急性加重期(AECOPD)痰湿蕴肺证的临床疗效。方法选取2022年1月—2022年12月临沂市中医医院收治的AECOPD痰湿蕴肺证患者80例,按照随机数表法均分为两组,各40例。两组均用常规治疗,观察组在常规西药治疗基础上联合加味小青龙汤治疗。计算两组临床疗效,观察两组咳嗽缓解时间、气喘消失时间、哮鸣音消失时间,治疗前后血清肿瘤坏死因子-α(TNF-α)、外周血白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)及用力肺活量(FVC)、第一秒用力呼气量(FEV_(1))、第一秒用力呼气量占用力肺活量的百分比(FEV_(1)/FVC)水平。结果观察组咳嗽缓解时间、气喘消失时间、哮鸣音消失时间均短于对照组,差异有统计学意义(P<0.05)。治疗后两组血清TNF-α、IL-6、hs-CRP水平较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗后两组肺功能FVC、FEV_(1)、FEV_(1)/FVC水平较治疗前改善,且观察组高于对照组,差异有统计学意义(P<0.05)。观察组总有效率明显优于对照组,差异有统计学意义(P<0.05)。结论小青龙汤加味治疗AECOPD痰湿蕴肺证,可以抑制炎症因子的表达,减少气道阻力,促进气道通畅,改善临床症状及肺功能,提高临床疗效。

北京市某三甲医院AECOPD发病影响因素调查的病例对照研究

目的 调查慢性阻塞性肺疾病急性加重期(AECOPD)发病的影响因素,为该病的防控提供理论依据。方法 选取2021年3月至2023年3月北京市朝阳医院就诊的AECOPD和稳定期COPD患者各334例,通过问卷收集患者资料,分析AECOPD发病的影响因素。结果 病例组患者吸烟、饮酒、大专及以上学历、过去1年使用过抗生素、过敏性鼻炎史、糖尿病史、高血压史、冠心病史、新冠肺炎患病史、住所1年内新购家具、住所1年内装修、住所1年内潮湿现象、住所内饲养皮毛宠物、过去1年被动吸烟的比例均高于对照组;住所内使用空调、空气净化器、房间清洁频率(经常)比例低于对照组。AECOPD患者在春季的占比最高,其次为秋季和冬季。住所1年内潮湿现象(OR=2.34,95%CI:1.21~4.53)、住所内饲养皮毛宠物(OR=4.82,95%CI:1.72~13.52)、过敏性鼻炎史(OR=5.23,95%CI:2.25~12.19)、高血压史(OR=2.15,95%CI:1.26~3.66)、新冠肺炎患病史(OR=5.80,95%CI:2.78~15.02)是AECOPD的危险因素,住所内使用空调(OR=0.41,95%CI:0.22~0.77)、住所内使用空气净化器(OR=0.37,95%CI:0.21~0.67)、房间清洁频率(偶尔、经常)(OR=0.33,95%CI:0.13~0.87;OR=0.30,95%CI:0.13~0.73)是AECOPD的保护因素。结论 AECOPD的发病受室内潮湿、皮毛宠物的饲养、空调和空气净化器的使用、房间清洁频率、过敏性鼻炎史、高血压史及新冠肺炎等多种因素的影响。

Expressions and significance of plasma ET-1 and IL-8 in patients with AECOPD merged with CHD

Objective:To observe the expressions and clinical significance of plasma ET-1 and IL-8 in patients with AECOPD merged with CHD.Methods: A total of 120 patients with AECOPD who were admitted in our hospital from February, 2015 to December, 2015 were included in the study and divided into observation 1 group (AECOPD merged with CHD) and observation 2 group (pure AECOPD) with 60 cases in each group. Moreover, 30 healthy individuals who came for physical examinations in the same period were served as the control group. ELISA was used to detect the plasma ET-1 and IL-8 levels, and their correlation was analyzed. The arterial blood gas and coagulation fibrinolysis indicators among the three groups were compared.Results: The plasma ET-1 and IL-8 levels in observation 1 and 2 groups were significantly higher than those in the control group. The plasma ET-1 and IL-8 levels in observation 1 group were significantly higher than those in observation 2 group. PaO2 in observation 1 and 2 groups was significantly lower than that in the control group, while PaCO2 was significantly higher than that in the control group. The comparison of PaO2 and PaCO2 between the two groups was not statistically significant. PT and APTT in observation 1 and 2 groups were significantly shortened when compared with the control group, while TT was significantly delayed. PT in observation 1 group was significantly shortened when compared with observation 2 group. Fbg and t-PA contents in observation 1 and 2 groups were significantly higher than those in the control group. Fbg, t-PA, and D-D contents in observation 1 group were significantly higher than those in observation 2 group.Conclusions:The hypercoagulation state is presenting in patients with AECOPD merged with CHD, with increased ET-1 and IL-8, both of which can play a synergistic effect, and are involved in the pathogenesis.

eCASH理念下的进阶式肺康复护理对COPD急性加重期患者的影响

目的:探讨eCASH理念下的进阶式肺康复护理对慢性阻塞性肺疾病(COPD)急性加重期患者的影响。方法:选取2022年5月1日~2023年9月30日收治的87例COPD急性加重期患者作为研究对象,随机分为对照组43例和干预组44例,对照组实施常规肺康复护理,干预组实施eCASH理念下的进阶式肺康复护理;比较两组干预前后疾病活动度[包括膈肌活动度(DE)、膈肌增厚分数(DTF)、气道阻力(Raw)、气道峰压(PIP)、气道平台压(Pplat)],临床指标及并发症发生情况。结果:干预14 d,两组DE、DTF均高于干预前(P<0.05),Raw、PIP、Pplat均低于干预前(P<0.05),且干预组优于对照组(P<0.01);干预组镇静达标时间、机械通气时间、ICU入住时间短于对照组(P<0.01),肌力评分高于对照组(P<0.01);干预组并发症发生率低于对照组(P<0.05)。结论:eCASH理念下的进阶式肺康复护理能有效控制COPD急性加重期患者疾病活动度,改善呼吸力学相关指标,缩短镇静达标、机械通气及ICU入住时间,提高肌力水平,防止不良事件发生。

早期活动联合气流冲击对AECOPD机械通气患者呼吸机相关性肺炎的预防作用

目的分析早期活动联合气流冲击法对慢阻肺急性加重期(AECOPD)机械通气患者呼吸机相关性肺炎(VAP)的预防作用。方法前瞻性纳入2021年5月至2023年5月收治的90例AECOPD患者进行随机对照研究,通过随机数字表法分为对照组和观察组,每组45例。对照组于机械通气期间接受常规干预联合气流冲击法干预,观察组在对照组基础上联合早期活动干预。2组均干预至拔管为止。对比2组VAP发生情况(VAP发生例数、VAP发生时间)、住院时间、机械通气时间和治疗期间不良事件(导管易位、堵管、气道损伤、压疮、拔管失败)发生情况,探讨早期活动联合气流冲击法对AECOPD机械通气患者VAP的预防作用。结果观察组VAP发生率、VAP发生时间显著低于对照组,差异有统计学意义(P<0.05)。观察组住院时间、机械通气时间显著少于对照组,差异有统计学意义(P<0.05)。2组治疗期间不良事件总发生率对比,差异无统计学意义(P>0.05)。结论早期活动联合气流冲击法可有效预防AECOPD机械通气患者VAP发生,且可缩短住院时间和机械通气时间,促进疾病更好康复。

AECOPD合并呼吸衰竭开展无创呼吸机联合高流量氧疗的效果

目的探讨慢阻肺急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并呼吸衰竭患者开展无创呼吸机联合高流量氧疗(high-flow nasal cannula,HFNC)的临床效果。方法选取2022年6月—2023年6月兖矿新里程总医院呼吸内科收治的AECOPD合并呼吸衰竭患者92例,根据治疗方法的不同分为对照组(n=46)与观察组(n=46)。对照组采用无创呼吸机治疗,观察组采用无创呼吸机联合HFNC治疗。对2组患者的并发症发生率、再插管率、治疗前后血气指标、肺功能及血清生化指标进行比较。结果观察组患者并发症总发生率为6.52%,明显低于对照组的21.74%(P<0.05)。观察组再插管率为2.17%,与对照组再插管率(8.70%)相比,差异无统计学意义(P>0.05)。治疗前组间患者血气指标、肺功能及血清生化指标比较,差异无统计学意义(P>0.05);治疗后观察组血气指标、肺功能及血清生化指标改善均优于对照组(P<0.05)。结论无创呼吸机联合HFNC对于AECOPD合并呼吸衰竭患者病情有良好地控制效果,能够改善其肺功能和呼吸功能,因此在临床中有较高的推广价值。

沙美特罗替卡松联合噻托溴铵对COPD急性加重期患者炎性反应及肺功能的影响

目的探讨沙美特罗替卡松联合噻托溴铵对COPD急性加重期(AECOPD)患者炎性反应及肺功能的影响。方法86例AECOPD患者随机分为两组。在常规治疗基础上,对照组给予噻托溴铵粉雾剂吸入治疗,观察组采用噻托溴铵粉雾剂吸入联合沙美特罗替卡松气雾剂治疗。比较两组的炎性因子、肺功能以及不良反应。结果治疗后,观察组的IL-8、TNF-α及hs-CRP水平均低于对照组,FEV_(1)、PEF、FVC均高于对照组(P<0.05)。两组治疗期间的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论沙美特罗替卡松联合噻托溴铵治疗AECOPD可显著减轻患者的炎性反应,改善患者的肺功能,且安全性较高。

异丙托溴铵联合布地奈德可改善COPD急性加重期患者肺功能和全身免疫炎性反应指数的影响

目的探究异丙托溴铵联合布地奈德可改善COPD急性加重期患者肺功能和全身免疫炎性反应指数的影响。方法选取我院2020年11月至2022年11月COPD急性加重期患者共100例,均行基础治疗。随机分为对照组与观察组两组,对照组50例,实施异丙托溴铵;观察组50例,联合应用异丙托溴铵溶液和吸入用布地奈德混悬液。比较两组患者治疗前后肺功能指标,IL-6(白介素6)、TNF-α(肿瘤坏死因子),全身免疫炎性反应指数(SIRI)变化。比较两组患者治疗后症状好转时间和临床疗效评估。统计两组患者不良反应发生情况。结果观察组患者治疗后临床有效率明显高于对照组患者(P<0.05)。观察组患者治疗后肺功能指标改善情况显著优于对照组患者(P<0.05)。观察组患者治疗后肺IL-6,TNF-α和SIRI与对照组患者相比明显降低(P<0.05)。对照组患者治疗过程中咳嗽缓解时间,气促消失时间,喘息消失时间和肺部体征消失时间明显长于观察组(P<0.05)。两组患者不良反应统计无差异(P>0.05)。结论布地奈德联合异丙托溴铵治疗COPD急性加重期患者可有效减轻患者炎症反应,改善患者肺功能,提升患者疗效,并且不会增加患者不良反应的发生。

苏子降气汤联合复方甲氧那明胶囊治疗COPD急性加重期患者的临床效果

目的:探讨苏子降气汤联合复方甲氧那明胶囊治疗慢性阻塞性肺疾病(COPD)急性加重期患者的临床效果。方法:选取2020年1月—2022年12月于启东市中医院呼吸内科治疗的100例COPD急性加重期患者作为研究对象,通过随机数表法分为对照组和观察组,各50例。对照组采用复方甲氧那明胶囊治疗,观察组在此基础上给予苏子降气汤治疗。比较两组临床疗效、治疗前后的中医症候积分(咳嗽、咳痰、喘息、哮鸣音及胸膈满闷)及炎症因子(C反应蛋白、降钙素原)。结果:观察组治疗有效率高于对照组,差异有统计学意义(P<0.05);治疗后,观察组咳嗽、咳痰、喘息、哮鸣音及胸膈满闷积分均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组C反应蛋白、降钙素原水平均低于对照组,差异有统计学意义(P<0.05)。结论:在COPD急性加重期患者中实施苏子降气汤联合复方甲氧那明胶囊治疗,可提高患者的临床有效率,改善中医症候积分,减轻炎症反应。

吸入用布地奈德混悬液与盐酸左沙丁胺醇雾化吸入溶液药物治疗急性加重期COPD的效果

目的观察急性加重期慢性阻塞性肺疾病(COPD)患者选择雾化吸入布地奈德与盐酸左沙丁胺醇治疗的价值。方法回顾性选取2022年2月至2023年2月漳浦县医院急性加重期COPD患者98例,依据用药方法的不同分为两组,各49例。联合用药组接受盐酸左沙丁胺醇雾化吸入溶液与吸入用布地奈德混悬液药物治疗,单独用药组接受单独吸入用布地奈德混悬液药物治疗,对两组血气分析与肺功能监测结果、凝血指标、临床疗效、症状控制与缓解时间、住院时间进行统计分析。结果联合用药组患者的氧分压(PaO_(2))、pH值、最大呼气流量(PEF)、第1秒用力呼气容积(FEV_(1))、用力呼气量(FVC)、FEV_(1)/FVC、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)均高于单独用药组(P<0.05),动脉血二氧化碳分压(PaCO_(2))低于单独用药组(P<0.05),总有效率高于单独用药组(P<0.05),急性发作控制时间与喘息、哮鸣音、咳嗽缓解时间及住院时间均短于单独用药组(P<0.05)。结论急性加重期COPD患者选择雾化吸入布地奈德与盐酸左沙丁胺醇的价值较高,更能对患者的血气分析与肺功能、凝血功能进行改善,临床疗效更为显著,且更能将患者的症状控制与缓解时间、住院时间缩短。

COPD急性加重期合并呼吸衰竭患者血清CysC、GGT水平与循环指标变化

目的 探讨慢性阻塞性肺疾病(COPD)急性加重期合并呼吸衰竭患者血清胱抑素C(CysC)、γ-谷氨酰基转移酶(GGT)及凝血纤溶指标、胸腔内血容积指数、血管外肺水指数变化和意义。方法 选取COPD急性加重期合并呼吸衰竭患者76例为合并呼吸衰竭组,即观察组,COPD急性加重期未并发呼吸衰竭患者50例为对照组。采集患者入院24 h内的空腹外周静脉血,离心分离血清和血浆,检测血清CysC、GGT水平及血浆抗凝血酶Ⅲ、纤溶酶原激活物抑制物-1、组织型纤溶酶原激活物浓度。采用经肺热稀释法测定胸腔内血容积指数、血管外肺水指数。收集两组患者性别、年龄、COPD病程及并发症情况,出院后进行6个月随访,根据不良预后发生情况将患者分为预后良好组和预后不良组。结果 合并呼吸衰竭组患者血清CysC、GGT水平明显高于对照组(P<0.05)。合并呼吸衰竭组患者血浆抗凝血酶Ⅲ、组织型纤溶酶原激活物浓度明显低于对照组,血浆纤溶酶原激活物抑制物-1浓度明显高于对照组(P<0.05)。合并呼吸衰竭组患者胸腔内血容积指数明显低于对照组,血管外肺水指数明显高于对照组(P<0.05)。预后不良组患者血清CysC、GGT水平及血浆纤溶酶原激活物抑制物-1浓度、血管外肺水指数明显高于预后良好组,血浆抗凝血酶Ⅲ、组织型纤溶酶原激活物浓度及胸腔内血容积指数明显低于预后良好组(P<0.05)。ROC曲线分析显示,血清CysC、GGT水平及抗凝血酶Ⅲ、纤溶酶原激活物抑制物-1、组织型纤溶酶原激活物、胸腔内血容积指数、血管外肺水指数对患者预后均具有较高的预测价值(P<0.05),各指标联合检测的预测价值最高(AUC=0.945)。结论 COPD急性加重期合并呼吸衰竭患者血清CysC、GGT水平及血浆纤溶酶原激活物抑制物-1浓度、血管外肺水指数明显升高,血浆抗凝血酶Ⅲ、组织型纤溶酶原激活物浓度及胸腔内血容积指数明显降低,联合检测在患者预后评估中具有较高的预测价值。